
Reset all filters
01 51Belmore Neidrauer LLP
Reset all filters
01 62663116
02 42800913
03 52851808
04 62875986
05 52928721
06 42976695
07 12991994
08 43007787
09 53007788
10 63015208
11 53022256
Reset all filters
01 51IBRUTINIB
Reset all filters
01 10CAPSULE
02 4SUSPENSION
03 37TABLET
Reset all filters
01 62026-12-28
02 182031-06-03
03 52032-10-19
04 132033-06-03
05 52034-10-24
06 42036-03-02
Patent Expiration Date : 2026-12-28
Date Granted : 2014-06-10
Brand Name : IMBRUVICA
Patent Number : 2663116
Filing Date : 2006-12-28
Strength per Unit : 140 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-12-28
Date Granted : 2014-06-10
Patent Expiration Date : 2031-06-03
Date Granted : 2019-07-23
Brand Name : IMBRUVICA
Patent Number : 2800913
Filing Date : 2011-06-03
Strength per Unit : 140 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-06-03
Date Granted : 2019-07-23
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-06-03
Date Granted : 2020-03-10
Brand Name : IMBRUVICA
Patent Number : 3007788
Filing Date : 2011-06-03
Strength per Unit : 140 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-06-03
Date Granted : 2020-03-10
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-10-24
Date Granted : 2020-12-22
Brand Name : IMBRUVICA
Patent Number : 2928721
Filing Date : 2014-10-24
Strength per Unit : 140 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2034-10-24
Date Granted : 2020-12-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-06-03
Date Granted : 2020-06-09
Brand Name : IMBRUVICA
Patent Number : 2875986
Filing Date : 2013-06-03
Strength per Unit : 140 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2033-06-03
Date Granted : 2020-06-09
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2026-12-28
Date Granted : 2014-06-10
Brand Name : IMBRUVICA
Patent Number : 2663116
Filing Date : 2006-12-28
Strength per Unit : 140 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-12-28
Date Granted : 2014-06-10
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-06-03
Date Granted : 2019-07-23
Brand Name : IMBRUVICA
Patent Number : 2800913
Filing Date : 2011-06-03
Strength per Unit : 140 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-06-03
Date Granted : 2019-07-23
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-06-03
Date Granted : 2020-03-10
Brand Name : IMBRUVICA
Patent Number : 3007788
Filing Date : 2011-06-03
Strength per Unit : 140 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-06-03
Date Granted : 2020-03-10
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-10-24
Date Granted : 2020-12-22
Brand Name : IMBRUVICA
Patent Number : 2928721
Filing Date : 2014-10-24
Strength per Unit : 140 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2034-10-24
Date Granted : 2020-12-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-06-03
Date Granted : 2020-06-09
Brand Name : IMBRUVICA
Patent Number : 2875986
Filing Date : 2013-06-03
Strength per Unit : 140 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2033-06-03
Date Granted : 2020-06-09
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF